Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4+ T cell depletion

AIDS Research and Human Retroviruses

Volumn 29, Issue 3, 2013, Pages 602-612

  Perez, Carina L ^a,b   Milush, Jeffrey M ^c   Buggert, Marcus ^d   Eriksson, Emily M ^c   Larsen, Mette V ^e   Liegler, Teri ^f   Hartogensis, Wendy ^c   Bacchetti, Peter ^f   Lund, Ole ^e   Hecht, Frederick M ^c   Nixon, Douglas F ^c   Karlsson, Annika C ^d  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; T CELL DEPLETION; VIRUS LOAD;

CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; EPITOPES; FLOW CYTOMETRY; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PLASMA; RNA, VIRAL; SAN FRANCISCO; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 84874458566     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0171     Document Type: Article

References (44)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8 + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68: 6103-6110.
2. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, et al.: The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009;206:1253-1272.
3. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
4. Norstrom MM, Buggert M, Tauriainen J, Hartogensis W, Prosperi MC, Wallet MA, et al.: Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B.5701 subjects. J Virol 2012;86:9802-9816.
5. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, O'Sullivan K M, et al.: Selective escape from CD8 + T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005;79:13239-13249.
6. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E, et al.: Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003;9:928-935.
7. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, et al.: Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996;272:537-542.
8. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, et al.: Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-1895.
9. Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, et al.: Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS One 2007;2:e225.
10. Hoof I, Perez CL, Buggert M, Gustafsson RK, Nielsen M, Lund O, et al.: Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity. J Immunol 2010;184:5383-5391.
11. Malhotra U, Nolin J, Horton H, Li F, Corey L, Mullins JI, et al.: Functional properties and epitope characteristics of Tcells recognizing natural HIV-1 variants. Vaccine 2009;27:6678-6687.
12. Goulder PJ and Watkins DI: Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008;8:619-630.
13. Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, et al.: Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog 2009;5:e1000365.
14. Miura T, Brumme ZL, Brockman MA, Rosato P, Sela J, Brumme CJ, et al.: Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol 2010;84:7581-7591.
15. Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, et al.: Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated in chronic infection. J Virol 2010;84:11937-11949.
16. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, et al.: HLA and HIV-1: Heterozygote advantage and B.35-Cw.04 disadvantage. Science 1999;283: 1748-1752.
17. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al.: HLA B.5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000;97:2709-2714.
18. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317:944-947.
19. Altfeld M, Kalife ET, Qi Y, Streeck H, Lichterfeld M, Johnston MN, et al.: HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8 (+) T cell response against HIV-1. PLoS Med 2006;3:e403.
20. Borghans JA, Molgaard A, de Boer RJ, and Kesmir C: HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS One 2007;2:e920.
21. Dinges WL, Richardt J, Friedrich D, Jalbert E, Liu Y, Stevens CE, et al.: Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J Virol 2010;84:4461-4468.
22. Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R, et al.: Protective HLA class I alleles that restrict acute-phase CD8 + T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol 2009;83: 1845-1855.
23. Julg B, Williams KL, Reddy S, Bishop K, Qi Y, Carrington M, et al.: Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses. J Virol 2010;84:5540-5549.
24. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al.: CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007;13:46-53.
25. Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, et al.: Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 2008;3:e1424.
26. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, et al.: Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 2006;80:3617-3623.
27. Peyerl FW, Bazick HS, Newberg MH, Barouch DH, Sodroski J, and Letvin NL: Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope. J Virol 2004;78:13901-13910.
28. Mlotshwa M, Riou C, Chopera D, de Assis Rosa D, Ntale R, Treunicht F, et al.: Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression. J Virol 2010;84:12018-12029.
29. Gray CM, Mlotshwa M, Riou C, Mathebula T, de Assis Rosa D, Mashishi T, et al.: Human immunodeficiency virusspecific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. J Virol 2009;83:470-478.
30. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, et al.: Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002;16:1119-1129.
31. Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, et al.: Human immunodeficiency virus type 1-specific CD8 + T-cell responses during primary infection are major determinants of the viral set point and loss of CD4 + T cells. J Virol 2009;83:7641-7648.
32. Perez CL, Larsen MV, Gustafsson R, Norstrom MM, Atlas A, Nixon DF, et al.: Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes. J Immunol 2008;180:5092-5100.
33. Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, Ronquillo R, et al.: Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigenspecific T cells. J Immunol Methods 2003;283:141-153.
34. Roederer M, Nozzi JL, and Nason MX: SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011;79:167-174.
35. Kahn JO and Walker BD: Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998;339:33-39.
36. The-International-HIV-Controllers-Study: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010;330:1551-1557.
37. Moore CB, John M, James IR, Christiansen FT, Witt CS, and Mallal SA: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002;296:1439-1443.
38. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, et al.: HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006;107:4781-4789.
39. Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, Martin JN, et al.: HIV + elite controllers have low HIVspecific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 2010;24:1095-1105.
40. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, et al.: Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med 2008;5:e100.
41. Couillin I, Culmann-Penciolelli B, Gomard E, Choppin J, Levy JP, Guillet JG, et al.: Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J Exp Med 1994;180:1129-1134.
42. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, et al.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-217.
43. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, et al.: Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991;354:453-459.
44. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, et al.: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-775.